EMA changes website section for regulatory information on human medicines

The European Medicines Agency (EMA) has simplified the navigation structure of the regulatory information on human medicines on its website in an attempt to improve site navigation and to make information easier and quicker to find.

The EMA had sought feedback from a wide range of industry stakeholders who use the EMA website for a variety of different purposes. The reorganisation reflected the feedback which showed that most users prefer to search for information based on the three main stages of the medicinal product lifecycle:

• research and development
• marketing authorisation
• post-authorisation.

For those who prefer to search by topic, the revamp may cause a bit of concern at first. However, the overview section includes an A to Z of topics to help users find information under topic headings that cut across the product lifecycle’. Each topic has its own landing page.

The EMA has said that it plans to reorganise the regulatory information on veterinary medicines in a similar manner by the end of this year.

To read more on the EMA announcement, click here and to go to the new regulatory information on human medicines page, please click here.